Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

35.82
Delayed Data
As of Feb 27
 -1.06 / -2.87%
Today’s Change
31.22
Today|||52-Week Range
52.58
-29.56%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash8.0M80.9M8.9M30.7M
 
 
 
 
 
Short Term Investment Cash6.4M3.7M-1.7M21.8M
 
 
 
 
 
Cash & Short Term Investments24.5M114.2M101.5M90.8M
 
 
 
 
 
 
ReceivablesReceivables261.0K2.9M1.6M1.7M
 
 
 
 
 
 
InventoriesInventories0.000.000.00----
 
Current AssetsOther Current Assets369.0K604.0K1.6M15.5M
 
 
 
 
 
Current Assets25.1M117.7M104.7M108.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.2M5.1M5.5M5.9M
 
 
 
 
 
Depreciation-4.6M-4.5M-4.3M-4.1M
 
 
 
 
 
Other Assets27.0K2.2M0.000.00
 
 
 
Total Assets26.1M122.6M117.0M155.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable566.0K1.9M1.5M1.9M
 
 
 
 
 
Accrued Expenses755.0K2.6M2.0M1.6M
 
 
 
 
 
Other Current Liabilities755.0K2.6M2.0M1.6M
 
 
 
 
 
Other Liabilities2.1M5.7M4.5M4.7M
 
 
 
 
 
 
Total LiabilitiesDeferred Taxes0.000.000.00-4.2M
 
 
Other Liabilities2.0M2.5M1.9M1.7M
 
 
 
 
 
Total Liabilities4.1M8.2M6.5M6.6M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock153.9M0.000.00202.0K
 
 
 
Common Equity-132.0M114.4M110.5M148.7M
 
 
 
 
 
Total Shareholder Equity22.0M114.4M110.5M148.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding16.8M16.8M17.9M18.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account